Medibank Broker Firm Allocations, page-227

Some comments that have come to light.
1. BUPA numbers available are for 2013 and thoughts by Instos are that they may be lower for 2014 and hence MPL may not be too far behind BUPA in terms of profitability. This may reduce price expectations for MPL post listing.
2. Overseas roadshow for USA did not seem to be easy from what I can make out. They do not have a comparable in the US for MPL and were struggling to come to terms with the low medical insurance costs in Australia compared with USA. Based on this there may be demand but not sure if they will be price leaders in the bidding process. This is good for moderating the IPO price I hope.
3. The debate whether MPL is an insurer or medical company still goes on. Believe this is why the high end of $2 is slap in the middle of insurers and medical stocks.
4. There is a lot of Insto demand. Only pricing is the issue now.
5. Some comments that broker firms were reduced in favour of public applications because in broker firm the government had to pay a 1% fee to brokers. For public pool there is no fee. Evidently government is very tight with expenses on this float. If correct, then do not expect a low IPO price ?
6. Hearing that some brokers did not allocate any stock to accounts with less than around $5000 in bro pa.
7. Hearing that 20% claw back of broker firms is probably a certainty and just lucky if it does not happen.